1.
Acta Academiae Medicinae Sinicae
;
(6): 278-282, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-776037
RESUMO
Multi-target anticancer drugs have a more comprehensive and extensive range of action,and there is an uncertain risk in the combination of two drugs.A case of acute toxicity induced by erlotinib combined with cabozantinib is reported in this article.